Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A 3D model of an arteriovenous malformation, which was used for surgical planning, from an actual patient who was treated successfully.
The Center conducts ongoing research to improve diagnostic and therapeutic approaches to cerebrovascular disease (CVD) in children. (See a sampling of our publications.) As we develop and implement new techniques, we update an extensive database that guides and informs our practice and helps us innovate. Our clinical research is complemented by basic science discoveries in the Vascular Biology Program.
3D printing to model brain and vascular anatomy
Working with Peter Weinstock, MD, PhD, of the Simulations group at Boston Children’s, Edward Smith, MD, and Darren Orbach, MD, PhD, are pioneering the creation of precision 3D models of individual patients’ brains and blood vessels, using the data from their brain scans. These models, created with special digitally guided printers that lay down different types of molten plastic in precision fashion, can be used to plan and rehearse surgical and neurointerventional maneuvers in advance. Read more.
New surgical treatments
Our neurosurgical team has developed surgical treatments for pediatric cavernous malformations. For children with moyamoya disease, we developed an operation known as pial synangiosis. It stimulates new blood vessels to grow in the brain and has been shown to be safe and effective in reducing stroke risk in children with moyamoya disease. Learn more.
Refining catheter procedures
A variety of novel techniques developed and trialed here have allowed safe use of catheters and endovascular devices in infants’ tiny vessels. Read more here and here.
We also successfully adopted Onyx®, an improved material used in the embolization of cerebrovascular lesions in adults, to treat cerebral and spinal arteriovenous malformations, vein of Galen malformations and dural arteriovenous fistulae in children. We have more experience using Onyx® in children than any other center, with an unparalleled safety record.
Neurosurgeon Edward Smith, MD, is beginning to identify telltale proteins in the urine of patients with cerebrovascular disorders, such as moyamoya disease and arteriovenous malformations. These “biomarkers” may help in diagnosing and monitoring CVD, reducing the need for children to travel to Boston Children’s for follow-up imaging studies. Dr. Smith has already validated the utility of urine biomarkers of several kinds of brain tumors. Read more.
CVD dynamic database
Our comprehensive patient database, representing the largest experience with pediatric cerebrovascular disease in the world, provides rich source material for ongoing studies. The database allows us to track long-term patient outcomes, compare the results of different surgical and neurointerventional procedures, evaluate newly adopted interventions and improve our quality of care.
For highlights of our previous research, see Selected Papers.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”